Product NDC: | 0173-0387 |
Proprietary Name: | CEFTIN |
Non Proprietary Name: | cefuroxime axetil |
Active Ingredient(s): | 250 mg/1 & nbsp; cefuroxime axetil |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0387 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050605 |
Marketing Category: | NDA |
Start Marketing Date: | 19891001 |
Package NDC: | 0173-0387-00 |
Package Description: | 20 TABLET, FILM COATED in 1 BOTTLE (0173-0387-00) |
NDC Code | 0173-0387-00 |
Proprietary Name | CEFTIN |
Package Description | 20 TABLET, FILM COATED in 1 BOTTLE (0173-0387-00) |
Product NDC | 0173-0387 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cefuroxime axetil |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19891001 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | CEFUROXIME AXETIL |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |